NEOGEN CORP (NEOG) SEC Filings & Financial Intelligence
NEOGEN CORP (NEOG) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NEOG
CIK: 711377
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 05/31
State: MI
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 5/31/2026 12:00:00 AM
Lead Engagement PartnerChristopher Hickmann
Audit LocationGrand Rapids, Michigan, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-04 | 2026-11-03 | PRIMARY DOCUMENT | 0000711377-26-000045 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-04 | 8-K | 0001193125-26-447166 | View SEC Doc Filr Page |
| 144 | 2026-11-04 | — | 144 Filing | 0001959173-26-007718 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-11-02 | PRIMARY DOCUMENT | 0000711377-26-000044 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-29 | PRIMARY DOCUMENT | 0000711377-26-000043 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000042 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-29 | PRIMARY DOCUMENT | 0000711377-26-000041 | View SEC Doc Filr Page |
| 3 | 2026-10-30 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000040 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-29 | PRIMARY DOCUMENT | 0000711377-26-000038 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-29 | PRIMARY DOCUMENT | 0000711377-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-29 | PRIMARY DOCUMENT | 0000711377-26-000036 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-29 | PRIMARY DOCUMENT | 0000711377-26-000035 | View SEC Doc Filr Page |
| 144 | 2026-10-28 | — | 144 Filing | 0001959173-26-007522 | View SEC Doc Filr Page |
| 8-K/A | 2026-10-26 | 2026-10-01 | 8-K/A | 0001193125-26-431208 | View SEC Doc Filr Page |
| 4 | 2026-10-23 | 2026-10-14 | PRIMARY DOCUMENT | 0000711377-26-000034 | View SEC Doc Filr Page |
| 3 | 2026-10-23 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000033 | View SEC Doc Filr Page |
| 3 | 2026-10-21 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000032 | View SEC Doc Filr Page |
| 3 | 2026-10-21 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000031 | View SEC Doc Filr Page |
| 3 | 2026-10-21 | 2026-10-01 | PRIMARY DOCUMENT | 0000711377-26-000030 | View SEC Doc Filr Page |
| S-8 | 2026-10-20 | — | S-8 | 0001193125-26-426222 | View SEC Doc Filr Page |
| S-8 | 2026-10-20 | — | S-8 | 0001193125-26-426212 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-09 | PRIMARY DOCUMENT | 0000711377-26-000029 | View SEC Doc Filr Page |
| 10-Q | 2026-10-07 | 2026-08-31 | 10-Q | 0001193125-26-416954 | View SEC Doc Filr Page |
| 8-K | 2026-10-07 | 2026-10-01 | 8-K | 0001193125-26-416247 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | 8-K | 0001193125-26-415544 | View SEC Doc Filr Page |